Your browser doesn't support javascript.
loading
Management of oropharyngeal squamous cell carcinoma.
Grégoire, V; Giraud, P; Vieillevigne, L; Maingon, P.
Affiliation
  • Grégoire V; Département de radiothérapie, centre Léon-Bérard, 28, rue Laennec, 69373 Lyon, France. Electronic address: vincent.gregoire@lyon.unicancer.fr.
  • Giraud P; Service d'oncologie radiothérapie, hôpital européen Georges-Pompidou, université de Paris, 20, rue Leblanc, 75015 Paris, France.
  • Vieillevigne L; Unité de physique médicale, institut Claudius-Regaud, Institut universitaire du cancer de Toulouse, 1, avenue Irène-Joliot-Curie, 31059 Toulouse, France.
  • Maingon P; Département de radiothérapie, Sorbonne Université, groupe hospitalier La Pitié-Salpêtrière, Assistance publique-hôpitaux de Paris, 75013 Paris, France.
Cancer Radiother ; 26(1-2): 174-188, 2022.
Article in En | MEDLINE | ID: mdl-34953693
ABSTRACT
This article reviews the various treatment options, by primary or postoperative external radiotherapy and by brachytherapy for the p16-negative oropharyngeal squamous cell carcinoma. Dose levels, fractionation and association with systemic treatments are presented. The need for neck node dissection post local treatment is discussed, as well as specificities for the management of p16-positive tumours. Guidelines for target volume selection and delineation are thoroughly elaborated. Last, the management by radiotherapy of locoregional recurrences is discussed.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oropharyngeal Neoplasms / Squamous Cell Carcinoma of Head and Neck Type of study: Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Cancer Radiother Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oropharyngeal Neoplasms / Squamous Cell Carcinoma of Head and Neck Type of study: Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Cancer Radiother Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2022 Type: Article